Clinical Trial Update: Mavacamten Enables Exercise in Hypertrophic Obstructive Cardiomyopathy [NA]

View source ↗

Summary

A clinical trial is evaluating mavacamten for patients with hypertrophic cardiomyopathy with obstructive features to assess its effect on exercise capacity; rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• Mavacamten (mavacamten)

Snippet

Sponsor: Technical University of Munich | Conditions: Cardiomyopathy, Hypertrophic | NA | Status: RECRUITING